Aclaris Therapeutics to Present at Jefferies 2019 Global Healthcare Conference

WAYNE, Pa., May 24, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced that management will present a company overview at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5, 2019 at 3:30 PM ET at the Grand Hyatt Hotel in New York, New York.

A live audio webcast of the presentation may be accessed through the Company's web site, www.aclaristx.com, on the 'Events' section. An archived version of the presentation will be available for 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a physician-led biopharmaceutical company committed to addressing the needs of people with immuno-inflammatory and dermatological diseases who lack satisfactory treatment options. The company’s diverse and multi-stage portfolio includes two FDA-approved medicines, one late-stage investigational medicine, and a pipeline powered by a robust R&D engine exploring protein kinase regulation. Aclaris Therapeutics’ active development programs focus on areas where significant treatment gaps exist, such as common warts, alopecia areata, and vitiligo. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn or Twitter @aclaristx.

Contact:Aclaris ContactMichael Tung, M.D.Senior Vice President Corporate Strategy/Investor Relations484-329-2140[email protected]

You May Also Be Interested In

• Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan
• Battery X Metals Provides Board of Directors Update
• Sia Ghaem, Mortgage Consultant, Announces Expanded Guidance for First Time and Self Employed Homebuyers in British Columbia